India Raised ₹1.85 Lakh Crore Through IPOs. And Most Investors Still Lost Money.

The greatest IPO boom in Indian history quietly became the greatest retail investor trap. Here’s the data nobody is talking about.

The headlines were intoxicating.

India, the world’s most active IPO market. ₹1.85 lakh crore raised in 2025 alone. Over 100 mainboard listings. Retail investors flooding in by the millions, armed with Zerodha accounts and dreams of listing-day wealth.

The narrative wrote itself: India’s rise. The democratisation of wealth. The retail investor revolution.

And then the data arrived.

As of March 2026, 64.1% of all IPOs that listed in 2025 are now trading below their offer price. The median loss across these IPOs stands at 17.71%. An investor who put money into a “typical” IPO of 2025 and held it didn’t just miss the bull run. They are sitting on losses while Sensex has moved on.

This is not a niche problem. This is the story of what actually happened to millions of ordinary Indian investors during the most celebrated IPO boom in the country’s history.

And almost nobody is talking about it.

The Boom Was Real. The Wealth Was Not.

Let’s start with what is undeniably true: India’s IPO market in 2024 and 2025 was, by every volumetric measure, a historic achievement.

In 2024, India fielded 327 IPOs raising $19.9 billion, nearly 30% of all global IPO activity, surpassing the United States, outpacing China, and cementing India’s position as the world’s most active primary market. Demat accounts crossed 171 million. SIP inflows hit a record $2.7 billion per month. Average IPO returns in 2024 hit an eye-catching 37.1%.

The momentum carried into 2025. A total of 108 mainboard IPOs raised ₹1,83,432 crore, a new record in absolute rupee terms. The pipeline was extraordinary. The excitement was real.

But buried inside these triumphant numbers was a quiet, gathering catastrophe for retail investors.

Median listing gains, the return a typical IPO investor actually experienced, collapsed from 15.2% in 2024 to just 3.8% in 2025. On listing day, 65% of IPOs did post a gain. But by year-end, 59% of those same IPOs had fallen below their listing price. The listing-day pop was not a profit. It was a temporary sugar rush before a long, painful hangover.

By March 2026, the picture had turned starkly worse. The average return across 2025 IPOs had dropped to -6.97%. More than half were trading below their offer price, some dramatically so.

Hexaware Technologies, one of the year’s marquee listings raising ₹8,750 crore, was down 41% from its listing price. Glottis, which had listed in the frenzied SME boom, had crashed 66% from its ₹129 offer price to ₹43.69.

This was not a bear market doing damage. This was the direct consequence of a structural problem with how retail investors were approaching India’s IPO boom and the flawed metrics they were using to make decisions.

The Three Myths That Cost Indian Investors Crores

Myth 1: “If the IPO is heavily oversubscribed, it will list at a big gain.”

This was perhaps the most widely held belief in India’s retail investing community, and the 2025 data demolished it comprehensively.

Seven IPOs in 2025 were subscribed over 100 times. Six of them either partially or fully eroded their listing gains within months. VMS TMT was subscribed an extraordinary 102.2 times and still listed with a negative return.

Meanwhile, PhysicsWallah was subscribed just 1.81 times, barely above the floor, and delivered a 33.03% listing gain.

Oversubscription measures how many people applied. It says almost nothing about whether the company’s business is worth the valuation at which it is being sold. In a market with 171 million demat accounts and millions of investors chasing listing-day gains through the lottery system, oversubscription has become a measure of FOMO, not fundamentals.

Myth 2: “A high GMP means a strong listing.”

The Grey Market Premium, that informal, unregulated price signal India’s investors obsessively track before every IPO, failed its believers repeatedly in 2025.

Multiple IPOs with strong GMPs and initial listing-day pops, including well-known names like Lenskart Solutions, Studds Accessories, and Orkla India, failed to sustain their valuations post-listing and delivered negative returns to investors who held beyond day one.

As Prashanth Tapse, Senior VP at Mehta Equities, stated bluntly in his year-end analysis: “Sentiment-driven indicators like GMPs often mislead investors. Disciplined fundamental analysis remains essential.”

GMP is a crowd-sourced sentiment poll operating in an unregulated shadow market. It reflects what grey market operators expect on listing day, not what the company is fundamentally worth over any meaningful investment horizon. An IPO with a high GMP and a P/E of 80x in a sector where peers trade at 20x is not an opportunity. It is a warning dressed in exciting clothes.

Myth 3: “You can’t go wrong with a well-known brand.”

The 2025 IPO cycle produced one of its most important and most painful lessons here.

JSW Cement. Dr Agarwal’s Healthcare. Ather Energy. WeWork India. These are not obscure companies. These are recognised, established names that listed at discounts to their issue prices despite subscriptions ranging from 1x to 49x.

Brand recognition is not a substitute for valuation discipline. A great company offered at an inflated price is a poor investment. In 2025’s IPO market, where over 60% of total IPO proceeds came from Offer For Sale (OFS), meaning existing shareholders were exiting rather than the company raising fresh growth capital, many “well-known brand” IPOs were essentially sophisticated promoter exits dressed up as investment opportunities.

What Separated the Winners From the Losers

Amid the carnage, some investors did exceptionally well. LG Electronics India delivered 50% returns from its issue price. Rubicon Research was up 31%. Highway Infrastructure surged 75% on listing day. Urban Company and Meesho each rallied 62% on debut.

What separated these from the disasters? The answer is consistently the same three factors:

1. Genuine fresh capital, not OFS exits. The IPOs that performed well in 2025 were predominantly those where the company itself was raising money to fund growth, not promoters cashing out. When a founder is selling shares at the IPO, they are telling you something about their assessment of value.
2. Sector tailwinds, not sector hype. LG Electronics, Rubicon Research, and PhysicsWallah each benefited from structural growth in their respective sectors: consumer electronics penetration, pharma/specialty chemicals, and EdTech. Understanding which sectors carry genuine momentum versus speculative froth is the single most underrated skill in IPO investing. India’s market spans 50+ industry sectors across NSE and BSE, each moving to its own cycle of institutional interest, policy support, and earnings growth. Investors who tracked real-time sector momentum, rather than simply following the IPO calendar, had a decisive informational advantage. Before applying to any IPO, smart investors were asking a simple question: is the sector this company operates in seeing institutional inflows or outflows right now? That one question, answered with live data, filtered out a majority of the 2025 disasters before they happened.
3. Valuation at a margin of safety, not at peak optimism. The best-performing 2025 IPOs shared one characteristic: their issue price represented a reasonable, even conservative, valuation relative to their earnings and growth trajectory. The worst performers were priced to perfection in a bull market, leaving no buffer when sentiment shifted.

The SME IPO Segment: A Cautionary Tale in Progress

If the mainboard story is sobering, the SME IPO segment in 2025 was, in parts, deeply alarming.

Of 238 SME IPO listings in 2025, 85 delivered listing-day losses of up to 45%. Companies with negligible revenues, unproven business models, and opaque promoter backgrounds were listing with grey market premiums that created an illusion of strong demand, and then collapsed.

Gem Aromatics debuted flat and subsequently dropped 56% as the company reported losses. Glottis listed 35% below its issue price and fell further to 54% below, as revenue growth failed to meet even modest expectations.

The SME IPO market in India operates under less stringent disclosure requirements than mainboard. The grey market for SME IPOs is even thinner and more susceptible to manipulation than mainboard GMP. And retail investors, many of them first-generation market participants with limited analytical tools, were the ones left holding the losses.

SEBI has responded with tightened regulations, including minimum EBITDA requirements and OFS caps for SME issuances. But regulation shapes what can list, not how investors evaluate what does list. That analytical responsibility remains with the investor.

How to Invest in IPOs Like the 10% Who Actually Made Money

The investors who consistently profited from India’s IPO market in 2025 were not smarter or luckier. They were more systematic. Here is the framework they used:

1. Start With Sector Before Stock

Every IPO inherits the sentiment of its sector. Before evaluating any specific company, assess whether its sector is in an uptrend or facing headwinds. A fintech company listing during regulatory tightening on lending faces different prospects than the same company listing during a credit expansion cycle. A defence company listing during a period of rising government capex has structural tailwinds that a standalone analysis of its P&L may understate.

Real-time sector intelligence, tracking where FII and DII flows are concentrated, which sectors are seeing institutional accumulation, is the foundation of intelligent IPO analysis, not an afterthought.

2. Use GMP as Sentiment, Not as Prediction

Before every IPO closes, take two minutes to check where the grey market premium is trending, not just what it is today, but whether it has been rising or falling over the subscription window. A rising GMP indicates genuine enthusiasm building. A falling GMP despite strong oversubscription is a red flag that sophisticated grey market participants are losing conviction.

But never, under any circumstances, use GMP as your only signal. As 2025 proved comprehensively, high GMP and heavy oversubscription are neither necessary nor sufficient conditions for positive returns.

3. Read the Red Herring Prospectus: At Least the Key Sections

You don’t need to read 400 pages. You need three things: the Objects of the Issue (why is the company raising money, and is there fresh capital or just OFS?), the Financials Summary (revenue growth, EBITDA margins, debt levels), and the Valuations section (what P/E are you paying, and how does it compare to listed peers?).

4. Check QIB Subscription: The Most Honest Signal

Qualified Institutional Buyers, including mutual funds, insurance companies, pension funds, and FPIs, have access to management meetings, detailed analyst coverage, and sophisticated valuation models. When QIBs oversubscribe heavily, they are putting institutional money on the line, not just filing lottery applications. QIB subscription is the most reliable demand signal in the entire IPO process. Retail investors who ignored GMP and focused on QIB subscription data navigated 2025 far better than those who did the opposite.

5. Have an Exit Plan Before You Apply

This sounds obvious. Almost nobody does it. Before applying for any IPO, decide: If this lists at a 10% gain, do I sell? If it lists flat, do I hold? If it lists at a 10% loss, do I cut?

The investors who were hurt most in 2025 were those who made implicit assumptions about holding for the long term without analysing whether the business warranted long-term holding at the listing valuation.

Looking Ahead: The 2026 Pipeline and What It Means

The IPO machine is not slowing down. Analysts project 190-200 companies will tap India’s capital markets in 2026, targeting aggregate fundraising of over ₹2.5 trillion, significantly higher than 2025.

The pipeline includes names that will generate enormous retail excitement. The FOMO will be real. The grey market premiums will be high on the hotly anticipated listings. WhatsApp groups will buzz with tips.

And some of those IPOs will be extraordinary long-term investments. And some will quietly destroy capital over the 12 months following their celebratory listing days.

The difference between which is which will not be determined by the GMP. It will not be determined by how many times the IPO was oversubscribed. It will be determined by the same factors that have always determined investment outcomes: the quality of the business, the reasonableness of the valuation, and the strength of the sector in which it operates.

India’s IPO market is the most exciting in the world. It is also, for the unprepared retail investor, one of the most dangerous.

The boom is real. The trap is real. The difference between the two is analysis.

For live IPO GMP tracking, real-time sector intelligence, and AI-powered fundamental analysis across 5,000+ NSE and BSE stocks, visit Bull Run, India’s most advanced stock research platform, trusted by 12,000+ investors.

Disclaimer: This article is for educational and informational purposes only. It does not constitute investment advice. All IPO investments carry market risk. Past performance is not indicative of future returns. Data sourced from PRIME Database, Business Standard, S&P Global Market Intelligence, and IndMoney IPO Review 2025. Always consult a SEBI-registered financial advisor before making investment decisions.